Leukemia

Top Story

New biomarkers and therapeutic target discoveries in molecular oncology

New biomarkers and therapeutic target discoveries in molecular oncology
HemOnc Today, November 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
Meeting News

Efficacy, safety must guide treatment sequencing decisions in chronic myeloid leukemia

November 7, 2018
NEW YORK — The approval of multiple tyrosine kinase inhibitors for chronic myeloid leukemia has greatly expanded the therapeutic armamentarium but also created a…
Feature

Melanoma surveillance could benefit patients with chronic lymphocytic leukemia

November 5, 2018
Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma could benefit from active melanoma surveillance, according to study results published in…

HemOnc Today launches Cell Therapy Next

November 5, 2018
THOROFARE, NJ – With the approval of two chimeric antigen receptor T-cell therapies in the past year, the need arose for quality information and education about…
More Headlines »
CME ABIM MOC

Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »
Video
Meeting News

VIDEO: ASCO features pivotal data readouts from AstraZeneca portfolio

June 17, 2018
More »
Resource Centers
Discoveries from ASH Leukemia

Discoveries from ASH Leukemia

CME

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »